Long-term safety and efficacy outcomes of the Acellular Tissue Engineered Vessel (ATEV) in extremity arterial trauma repair

Symvess use for arterial reconstruction in setting of limb threatening arterial injury is associated with low infection rates, and acceptable limb salvage outcomes over 36 months in a high-risk trauma population when use of saphenous vein was not feasible. These results suggest Symvess represents a new alternative when autologous vein is not feasible for arterial reconstruction in extremity trauma.